Quantcast
Last updated on April 17, 2014 at 21:23 EDT

Latest Postherpetic neuralgia Stories

2013-04-09 12:27:26

Greater Reduction in Pain Intensity is One of the Greatest Unmet Needs in Postherpetic Neuralgia, According to a New Report from Decision Resources BURLINGTON, Mass., April 9, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed U.S. and European neurologists agree that reduction in pain intensity is one of the attributes that most influences their decisions regarding prescribing...

2013-03-17 23:03:03

Thousand oaks based pain management center is expanding services to include advanced diagnostic imaging. Thousand Oaks, California (PRWEB) March 17, 2013 Comprehensive Pain Management Center (CPMC) in Thousand Oaks, California has been treating patients for moderate to severe pain since 2012. Beginning April 1st, 2013 CPMC will include advanced diagnostic imaging services on site. Dr. Lin and the Comprehensive Pain Management Center have recently acquired a GE 1.5 Tesla 450-Watt, Open...

2013-03-13 16:26:08

NEWARK, Calif., March 13, 2013 /PRNewswire/ -- Depomed, Inc. (NASDAQ:DEPO) today announced that it will be presenting at the Roth Capital Partners 25th Annual Growth Stock Conference at the Ritz-Carlton Hotel in Dana Point, California. The presentation at the Roth conference is scheduled for 11:30 am PDT (2:30 pm EDT) on Tuesday March 19, 2013. The presentation will be webcast, and the webcast can be accessed via the Investor Relations page of the Depomed website at www.depomed.com. A...

2013-02-26 16:27:11

NEWARK, Calif., Feb. 26, 2013 /PRNewswire/ -- Depomed, Inc. (NASDAQ:DEPO) today announced that it will be presenting at the Cowen and Company 33rd Annual Health Care Conference at the Boston Marriott Copley Place Hotel in Boston. The presentation at the Cowen conference is scheduled for 10:00 am EST (7:00 am PST) on Tuesday, March 5, 2013. The presentation will be webcast, and the webcast can be accessed via the Investor Relations page of the Depomed website at www.depomed.com. A recording...

2013-02-13 16:26:49

NEWARK, Calif., Feb. 13, 2013 /PRNewswire/ -- Depomed, Inc. (NASDAQ:DEPO) today announced that it will release fourth quarter fiscal year 2012 financial results after the market closes on Wednesday, February 20, 2013. The Company will host a conference call beginning at 4:30 pm Eastern time, 1:30 pm California time to discuss its results. Participants can access the call by dialing 877-317-6789 (United States) or 412-317-6789 (international). The conference call will also be...

2012-12-26 16:20:51

NEWARK, Calif., Dec. 26, 2012 /PRNewswire/ -- Depomed, Inc. (NASDAQ: DEPO) today announced that its lawsuits against two filers of Abbreviated New Drug Applications (ANDAs) for Gralise(®) (gabapentin) have been dismissed. Watson Laboratories has withdrawn its Gralise ANDA. Par Pharmaceutical has amended its Gralise ANDA and is no longer seeking approval of the ANDA prior to the expiration of Depomed's patents listed for Gralise in the FDA publication commonly known as the Orange Book....

2012-12-24 05:00:10

Renowned directory Cleveland posted an article last month about the extreme pain shingles can cause and the blisters which follow. VyGone introduced vaccine to eradicate the blisters and treat Shingles on http://www.ultimatecoldsoretreatment.com. Boise, ID (PRWEB) December 23, 2012 Cleveland.com posted an article on on the 27th of November about shingles and the pain cause by shingles. It quoted Dr. Christopher Gharibo, who is a medical director at the NYU Hospital for joint disease,...

2012-12-10 04:21:36

MELBOURNE, Australia, December 10, 2012 /PRNewswire/ -- Spinifex Pharmaceuticals, an Australian pain drug development company, today announces that the first patients have been treated in its Phase 2 study of EMA401 in Chemotherapy-Induced Peripheral Neuropathy (CIPN), a painful and debilitating condition that develops in some patients receiving cancer chemotherapy. The study is an open label biomarker study being conducted at Hammersmith Hospital, London, UK. The trial...

2012-12-03 16:24:22

NEWARK, Calif., Dec. 3, 2012 /PRNewswire/ -- Depomed, Inc. (NASDAQ: DEPO) today announced that it will be presenting at the Oppenheimer 23rd Annual Healthcare Conference at the Waldorf Astoria Hotel in New York City. The presentation at the Oppenheimer conference is scheduled for 10:35 am EST (7:35 am PST) on Wednesday, December 12, 2012. The presentation will be webcast, and the webcast can be accessed via the Investor Relations page of the Depomed website at www.depomed.com. A recording...

2012-11-19 16:29:51

MENLO PARK, Calif., Nov. 19, 2012 /PRNewswire/ -- Depomed, Inc. (NASDAQ:DEPO) today announced that it will be presenting at the Piper Jaffray 24(th) Annual Healthcare Conference at the Palace Hotel in New York City. The presentation at the Piper conference is scheduled for 10:00 am EST (7:00 am PST) on Tuesday, November 27, 2012. The presentation will be webcast, and the webcast can be accessed via the Investor Relations page of the Depomed website at www.depomed.com. A recording of the...


Latest Postherpetic neuralgia Reference Libraries

69_7b87211f9314eacab994d465558a3a1b
2011-01-24 12:56:26

Herpes zoster (or zoster), is known as shingles or zona and is a viral disease characterized by painful skin rash with blisters in a limited area on one side of the body. Initial infection causes chickenpox. Once chickenpox is over the virus remains in the body and can cause shingles. It can become latent in the nerve cell bodies and sometimes in the dorsal root, cranial nerve, or autonomic ganglion. Years after initial infection, another breakout can cause a painful rash. The rash usually...

More Articles (1 articles) »